AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

11,790.00p
   
  • Change Today:
    -842.00p
  • 52 Week High: 15,316.00
  • 52 Week Low: 10,922.00
  • Currency: UK Pounds
  • Shares Issued: 1,551.02m
  • Volume: 1,102,226
  • Market Cap: £182,866m
  • RiskGrade: 123
  • Beta: 0.00

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue ($m) Pre-tax ($m) EPS Dividend
30-Jun-26 Interim 30,672.00 6,713.00 360.00¢ 106.00¢

Key Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 37,417.00 (265.00) 8.00¢ 1,459.9 n/a -97% 287.00¢ 2.5%
31-Dec-22 44,351.00 2,501.00 212.00¢ 71.2 0.0 +2,550% 290.00¢ 1.9%
31-Dec-23 45,811.00 6,899.00 726.00¢ 19.6 0.1 +242% 290.00¢ 2.0%
31-Dec-24 54,073.00 8,691.00 454.00¢ 31.0 n/a -38% 310.00¢ 2.2%
31-Dec-25 58,739.00 12,402.00 660.00¢ 28.1 0.6 +45% 320.00¢ 1.7%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Forecasts data is not available for this company.

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 1466.98 18.60 321.32 0.08

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

AstraZeneca Market Data

Currency UK Pounds
Share Price 11,790.00p
Change Today -842.00p
% Change -6.67 %
52 Week High 15,316.00
52 Week Low 10,922.00
Volume 1,102,226
Shares Issued 1,551.02m
Market Cap £182,866m
Beta 0.00
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average
90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average
Price Trend
9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Income
68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 06-Aug-26 19-Feb-26
Paid 08-Sep-26 23-Mar-26
Amount 106.00¢ 217.00¢

Trades for 03-Aug-2026

Time Volume / Share Price
09:11 0 @ 11,792.00p
09:11 4 @ 11,792.00p
09:11 0 @ 11,792.00p
09:11 11 @ 11,790.00p
09:11 0 @ 11,790.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page